Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2010, Article ID 401581, 5 pages
http://dx.doi.org/10.4061/2010/401581
Review Article

Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women

1Internal Medicine Department, Rio Hortega University Hospital, Faculty of Medicine, 47013 Valladolid, Spain
2Institute of Endocrinology and Nutrition Research Support Unit, Rio Hortega University Hospital, Faculty of Medicine, 47005 Valladolid, Spain
3RETICEF, 47013 Valladolid, Spain
4Clinical Pharmacology Service, Rio Hortega University Hospital, Valladolid, Spain
5Department of Ginecology, Hospital Rio Carrion, 34005 Palencia, Spain

Received 13 January 2010; Accepted 12 April 2010

Academic Editor: Michael Lewiecki

Copyright © 2010 José Luis Pérez-Castrillón et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

José Luis Pérez-Castrillón, Florentino Pinacho, Daniel De Luis, María Lopez-Menendez, and Antonio Dueñas Laita, “Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women,” Journal of Osteoporosis, vol. 2010, Article ID 401581, 5 pages, 2010. https://doi.org/10.4061/2010/401581.